Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: A nested case-control study

@inproceedings{Wakeham2015TrendsIK,
  title={Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: A nested case-control study},
  author={Katie Wakeham and William T Johnston and Angela Nalwoga and E L Webb and Billy Nsubuga Mayanja and Wendell J Miley and Alison M Elliott and Denise Whitby and Robert Newton},
  booktitle={International journal of cancer},
  year={2015}
}
HIV-associated Kaposi's sarcoma (KS) is a public health challenge in sub-Saharan Africa since both the causative agent, Kaposi's sarcoma associated-herpesvirus (KSHV), and the major risk factor, HIV, are prevalent. In a nested case-control study within a long-standing clinical cohort in rural Uganda, we used stored sera to examine the evolution of antibody titres against the KSHV antigens K8.1 and latency-associated nuclear antigen (LANA) among 30 HIV-infected subjects who subsequently… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 36 references

Effect of pregnancy on immunological and virological outcomes of women on ART: a prospective cohort study in rural Uganda, 2004–2009

  • BN Mayanja, LA Shafer, L Van der Paal
  • Trop Med Int Health 2011;12:920–8
  • 2011

Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission

  • S de Sanjose, G Mbisa, S Perez-Alvarez
  • J Infect Dis 2009;199:1449–56
  • 2009

Similar Papers

Loading similar papers…